feedback

Faculty

Jorge E. Cortes
Jorge E. Cortes, MD

D. B. Lane Cancer Research
Distinguished Professor for Leukemia Research
Deputy Chairman, Section Chief of AML & CML
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX

Uma Borate
Uma Borate, MD, MS

Assistant Professor
Department of Medicine
Division of Hematology/Oncology
University of Alabama at Birmingham
Birmingham, AL

Rami S. Komrokji
Rami S. Komrokji, MD

Clinical Director
Malignant Hematology Department
Lead Clinical Investigator for the MDS Program
H. Lee Moffitt Cancer Center
Tampa, FL

Srdan Verstovsek
Srdan Verstovsek, MD, PhD

Professor of Medicine
Director, Hanns A. Pielenz Clinical Research Center
for Myeloproliferative Neoplasms
Department of Leukemia
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX

Accredited By


Physicians' Education Resource®, LLC

Resources

Click here for additional educational resources for this activity.

Activity Details

Credit Type: AMA PRA Category 1 Credits
Credit Amount: 2
Release Date: July 31, 2014
Expiration Date: July 31, 2015
Estimated Time to Complete Activity: 2 hours
Fee for Activity: Free of Charge

Activity Description

OncoLogue is a dialogue among a multidisciplinary panel of experts that reflects real-world clinical discussions. It allows participants to hear and see thought leaders discuss patient management and treatment issues, experience case-based learning, and digest evidence-based commentary regarding treatment decisions.

The activity will include four clinical scenarios with which participants may engage: a patient diagnosed with chronic myeloid leukemia (CML), one with myelofibrosis (MF), one with myelodysplastic syndrome (MDS), and one with acute myeloid leukemia (AML).

Agenda

Topics for discussion include patients with the following hematologic malignancies:

  • Chronic myeloid leukemia
  • Myelofibrosis
  • Myelodysplastic syndrome
  • Acute myeloid leukemia

Learning Objectives

At the conclusion of this activity, participants should be better prepared to:

  • Compare efficacy and safety data of currently available treatment options for patients with hematologic malignancies
  • Describe current strategies for individualizing therapy for patients with newly diagnosed hematologic malignancies based on assessment of transplant eligibility, patient and tumor characteristics, and risk/benefit profiles of available regimens
  • Describe biomarkers that have been integrated into risk assessment and treatment selection paradigms for patients with hematologic malignancies
  • Summarize optimal supportive care strategies for preventing and treating side effects related to hematologic malignancies or their treatment

Target Audience

This online activity is directed toward community-based medical oncologists/hematologists and fellows who treat patients with hematologic malignancies.

Requirements for Successful Completion

In order to receive a CME certificate, participants must view the OncoLogue: Cases in Chronic Myeloid Leukemia, Myelofibrosis, Myelodysplastic Syndromes, and Acute Myeloid Leukemia, complete the posttest, and complete the evaluation and request for credit. Participants may immediately download a CME certificate upon completion of these steps.

Media

Internet-based

Conflict of Interest Policy / Disclosure Statement

The following individuals have relevant financial relationships with commercial interests to disclose:

Jorge E. Cortes, MD – Grant/Research Support: Ariad Pharmaceuticals, Bristol-Myers Squibb, Novartis, Pfizer, Incyte Corporation, sanofi-aventis; Consultant: Ariad, Bristol-Myers Squibb, Novartis, Pfizer, Inctye sanofi-aventis

Rami S. Komrokji, MD – Grant/Research Support: Incyte Corporation; Consultant: Incyte Corporation; Speaker's Bureau: Incyte Corporation

Srdan Verstovsek, MD, PhD – Grant/Research Support: Incyte Corporation, AstraZeneca, Lilly Oncology, Roche, Geron Corporation, NS Pharma, Bristol-Myers Squibb, Novartis, Celgene Corporation, Infinity Pharmaceuticals, YM BioSciences, Gilead Sciences, Seattle Genetics, Promedior, Cell Therapeutics, Inc., Gala Pharmaceuticals, Pfizer

The following individuals have no relevant financial relationships with commercial interests to disclose: Uma Borate, MD , MS
Physicians' Education Resource®, LLC, Planning Staff – David Lee, PhD and Francie Jallad

Accreditation Statement for Physicians

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation of Credit

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Statement of Commercial Support

This activity is supported by an educational grant from Incyte Corporation and Teva Pharmaceuticals.

Disclaimer Statement

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of Physicians' Education Resource®, LLC, or the company that provided commercial support for this CME activity.

Disclosure of Unlabeled Use

This CME activity may contain discussions about off-label/unapproved uses of drugs. For additional information about approved uses, including approved indications, contraindications, and warnings, participants are advised to consult prescribing information for all products discussed or consult the Physicians' Desk Reference. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient's medical condition.

Contact Information for Questions About the Activity

Physicians' Education Resource®, LLC
666 Plainsboro Road, Suite 356
Plainsboro, NJ 08536
Phone: (888) 949-0045
E-mail: info@gotoper.com

Hardware / Software Requirements

OpenCME recommends using the latest versions of these supported browsers: Google Chrome, Microsoft Internet Explorer, Mozilla Firefox, Safari. Depending on your browser of choice, additional software, such as Adobe Reader® and Adobe® Flash® Player may be required.

Download From the ITunes App Store now!

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.